Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma,
Location: Toronto, Dallas TX, San Antonio TX
Sponsor: Auricula Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07148128

Phase 1, Phase 2, Recruiting

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

for
Neoplasms
Location: Toronto, Montreal, Philadelphia PA, San Antonio TX
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07438782

Phase 1, Recruiting

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

for
Solid Malignancies
Location: Miami FL, Dothan AL, Houston TX, Palo Alto CA
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT07505771

Phase 1, Recruiting

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

for
Gynecologic Cancer, Hereditary Cancer Syndrome
Location: Queens NY, New York NY, Brooklyn NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT05562778

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

for
Neoplasms
Location: New Haven CT, Toronto, Sarasota FL, Houston TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06884618

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors

for
Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06651593

Phase 2, Recruiting

Re-Engaging AYA Survivors in Cancer-Related Healthcare

for
Cancer
Location: Philadelphia PA, Columbus OH
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 15 - 29

Code: NCT07138040

Recruiting

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

for
Solid Tumor Malignancies, Metastatic Cancer, Breast Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06896162

Recruiting

PET [89Zr]DFO-starPEG in Solid Tumors

for
Solid Tumor, Solid Carcinoma, Soft Tissue Lesion
Location: San Francisco CA
Sponsor: Robert Flavell, MD, PhD

Sex: All

Age: 18+

Code: NCT06894745

Phase 1, Recruiting

FAMILY Sleep Program

for
Cancer
Location: Coral Gables FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06571305

Recruiting

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

for
Neoplasms
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07382817

Phase 1, Recruiting

Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors

for
Survivorship, Recurrent, Recurrence, Cancer, Remission
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07030686

Recruiting

A Study of HS-20110 in Participants With Advanced Solid Tumors

for
Solid Tumors
Location: Fairfax VA, Tamarac FL, Huntersville NC, Atlanta GA,
Sponsor: Hansoh BioMedical R&D Company

Sex: All

Age: 18+

Code: NCT06892379

Phase 1, Recruiting

Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

for
Cancer, Breast Cancer
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: Female

Age: 20 - 70+

Code: NCT07023887

Recruiting

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

for
Cancer, Breast Cancer, Colorectal Cancer, Sarcoma, Lymphoma,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 39

Code: NCT06371768

Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for
Advanced Solid Tumors, Malignant Neoplasm
Location: Hackensack NJ, Richmond VA, Miami FL, Birmingham AL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06818643

Phase 1, Phase 2, Recruiting

Comprehensive Tobacco Cessation for Cancer Patients and Survivors

for
Tobacco Use Cessation, Cancer
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: All

Age: 18+

Code: NCT05805722

Recruiting

Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)

for
Cancer in Adolescence
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 15+

Code: NCT06950983

Recruiting

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumors
Location: East Brunswick NJ, New Brunswick NJ, Washington D.C. DC,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07123103

Phase 1, Recruiting

SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas

for
Non Hodgkin Lymphoma, Solid Tumor
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT07222631

Phase 1, Phase 2, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial